Mr. Chair, we responded publicly to the expert review panel. However, I must remind members that our top priority is to have the NRU up and running. We announced $48 million in our 2010 budget to support research, development and demonstration of new technologies and alternatives, establish a clinical trials network and optimize the use of isotopes in the health system. These initiatives are consistent with the recommendations of the panel.
What the hon. member does not say is that it is with a new multipurpose research reactor. The expert panel said that we would be provided with a business case, which is not the fact now. We cannot build a new reactor on the isotope production itself. It is not viable, which is what the experts said.